Acitretin
CAS No. 55079-83-9
Acitretin( all-trans Acitretin | Ro 10-1670 | Ro 10-1670/000 )
Catalog No. M14992 CAS No. 55079-83-9
Acitretin(Ro 10-1670) is a second-generation, systemic retinoid that has been used in the treatment of psoriasis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 100 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAcitretin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAcitretin(Ro 10-1670) is a second-generation, systemic retinoid that has been used in the treatment of psoriasis.
-
DescriptionAcitretin(Ro 10-1670) is a second-generation, systemic retinoid that has been used in the treatment of psoriasis.(In Vivo):Acitretin (10 mg/kg; i.p. for 7 days) increases IL-6 in the central nervous system of Alzheimer’s disease model mice.
-
In Vitro——
-
In Vivo——
-
Synonymsall-trans Acitretin | Ro 10-1670 | Ro 10-1670/000
-
PathwayMetabolic Enzyme/Protease
-
TargetRetinoid Receptor
-
RecptorRAR| RXR
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number55079-83-9
-
Formula Weight326.43
-
Molecular FormulaC21H26O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 20 mg/mL (61.26 mM)
-
SMILESCC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
-
Chemical Name(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Orfanos CE, et al. Drugs. 1997 Mar;53(3):358-88.
molnova catalog
related products
-
KCL-286
KCL-286 is an orally available and potent retinoic acid receptor beta agonist for the amelioration of spinal cord injury (SCI).
-
Bexarotene
Bexarotene is a retinoid specifically selective for retinoid X receptors, used as an oral antineoplastic agent in the treatment of cutaneous T-cell lymphoma.
-
PA452
PA452 is a retinoic X receptor (RXR) specific antagonist. PA452 suppresses the effect of Retinoic acid (RA) on Th1/Th2 development.
Cart
sales@molnova.com